The role of antigen-presenting cells in the pathogenesis of COVID-19

Area of Science:

• Immunology
• Virology
• Pathology

Background:

• Coronavirus Disease 2019 (COVID-19) is a significant global health threat, characterized by a dangerous "cytokine storm."
• The cytokine storm involves an exaggerated immune response leading to widespread tissue and organ damage.
• Antigen-presenting cells (APCs) play a pivotal role in orchestrating immune responses to viral infections.

Purpose of the Study:

• To investigate the critical role of antigen-presenting cells (APCs) in the pathogenesis of SARS-CoV-2 infection.
• To review the impact of immunological treatments, specifically monoclonal antibodies, on COVID-19.
• To elucidate the function of APCs in the context of the COVID-19 cytokine storm.

Main Methods:

• Literature review of existing research on COVID-19, SARS-CoV-2, immunology, and antigen-presenting cells.
• Analysis of the mechanisms underlying the cytokine storm in COVID-19.
• Examination of the diagnostic and therapeutic applications of monoclonal antibodies related to APC function.

Main Results:

• APCs are central to initiating and modulating the immune response against SARS-CoV-2.
• Dysfunctional APC activity contributes to the severity of the cytokine storm and subsequent organ damage.
• Monoclonal antibodies show potential in diagnosing and treating COVID-19 by targeting viral components and modulating immune responses.

Conclusions:

• Understanding APCs' role is essential for developing effective COVID-19 treatments.
• Targeting APCs and their interactions may mitigate the cytokine storm and improve patient outcomes.
• Further research into APCs and monoclonal antibodies will advance COVID-19 diagnosis and therapy.